Sterling Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $830K | Sell |
34,466
-671
| -2% | -$17.6K | 0.46% | 42 |
|
|
2026
Q1 | $987K | Sell |
35,137
-294
| -0.8% | -$7.83K | 0.59% | 37 |
|
|
2025
Q4 | $882K | Buy |
+35,431
| New | +$893K | 0.5% | 46 |
|
|
2020
Q4 | – | Sell |
-43,044
| Closed | -$1.5M | – | 63 |
|
|
2020
Q3 | $1.5M | Buy |
43,044
+3,569
| +9% | +$125K | 1.12% | 30 |
|
|
2020
Q2 | $1.23M | Buy |
39,475
+16,630
| +73% | +$565K | 0.95% | 35 |
|
|
2020
Q1 | $707K | Buy |
22,845
+12,066
| +112% | +$411K | 0.62% | 39 |
|
|
2019
Q4 | $401K | Sell |
10,779
-79
| -0.7% | -$2.81K | 0.27% | 54 |
|
|
2019
Q3 | $370K | Sell |
10,858
-29,216
| -73% | -$1.06M | 0.27% | 51 |
|
|
2019
Q2 | $1.65M | Sell |
40,074
-1,109
| -3% | -$44K | 1.27% | 24 |
|
|
2019
Q1 | $1.66M | Buy |
41,183
+20,994
| +104% | +$841K | 1.29% | 25 |
|
|
2018
Q4 | $836K | Buy |
20,189
+473
| +2% | +$19.6K | 0.7% | 30 |
|
|
2018
Q3 | $824K | Sell |
19,716
-196
| -1% | -$7.54K | 0.6% | 37 |
|
|
2018
Q2 | $685K | Sell |
19,912
-14,635
| -42% | -$500K | 0.53% | 38 |
|
|
2018
Q1 | $1.16M | Sell |
34,547
-21,381
| -38% | -$735K | 0.94% | 31 |
|
|
2017
Q4 | $1.92M | Buy |
55,928
+709
| +1% | +$24.2K | 2.05% | 21 |
|
|
2017
Q3 | $1.87M | Sell |
55,219
-2,739
| -5% | -$88K | 2.54% | 15 |
|
|
2017
Q2 | $1.85M | Sell |
57,958
-390
| -0.7% | -$12.3K | 2.44% | 17 |
|
|
2017
Q1 | $1.89M | Sell |
58,348
-2,939
| -5% | -$92.7K | 2.65% | 14 |
|
|
2016
Q4 | $1.89M | Sell |
61,287
-1,898
| -3% | -$57.9K | 2.7% | 13 |
|
|
2016
Q3 | $2.03M | Sell |
63,185
-110
| -0.2% | -$3.68K | 2.97% | 11 |
|
|
2016
Q2 | $2.11M | Sell |
63,295
-2,410
| -4% | -$76.9K | 2.89% | 10 |
|
|
2016
Q1 | $1.85M | Sell |
65,705
-24,196
| -27% | -$691K | 2.51% | 12 |
|
|
2015
Q4 | $2.75M | Sell |
89,901
-7,913
| -8% | -$249K | 2.38% | 13 |
|
|
2015
Q3 | $2.92M | Sell |
97,814
-1,560
| -2% | -$50K | 2.29% | 14 |
|
|
2015
Q2 | $3.16M | Sell |
99,374
-3,794
| -4% | -$124K | 2.38% | 14 |
|
|
2015
Q1 | $3.4M | Sell |
103,168
-4,674
| -4% | -$149K | 2.4% | 11 |
|
|
2014
Q4 | $3.19M | Sell |
107,842
-891
| -0.8% | -$25.5K | 2.2% | 14 |
|
|
2014
Q3 | $3.05M | Buy |
108,733
+385
| +0.4% | +$10.8K | 2.13% | 16 |
|
|
2014
Q2 | $3.05M | Sell |
108,348
-1,397
| -1% | -$39.8K | 2.14% | 16 |
|
|
2014
Q1 | $3.34M | Sell |
109,745
-88
| -0.1% | -$2.62K | 2.46% | 12 |
|
|
2013
Q4 | $3.19M | Sell |
109,833
-1,217
| -1% | -$35.4K | 2.3% | 15 |
|
|
2013
Q3 | $3.03M | Buy |
111,050
+46
| +0% | +$1.25K | 2.12% | 18 |
|
|
2013
Q2 | $2.95M | Buy |
+111,004
| New | +$3.07M | 2.09% | 18 |
|
Other funds holding PFE
AIM
CWP
DADC
WG
Sterling Investment Management's PFE Position: Q2 2026 in Review
Sterling Investment Management reduced its Pfizer (PFE) stake by 1.9% in Q2 2026, selling an estimated $17.6K and leaving 34,466 shares worth $830K. The position accounts for 0.46% of the portfolio, ranked #42.
Sterling Investment Management first reported a position in PFE in Q2 2013 and has held it in 33 quarters since. The position peaked at $3.4M in Q1 2015. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sterling Investment Management held 34,466 shares of Pfizer worth $830K as of Q2 2026.
- Sterling Investment Management sold 671 Pfizer shares in Q2 2026, an estimated $17.6K.
- Pfizer made up 0.46% of Sterling Investment Management's portfolio in Q2 2026, its #42 holding.
- Sterling Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 33 quarters since.
- Sterling Investment Management's Pfizer position peaked at $3.4M in Q1 2015.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sterling Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.